APA
Mileshkin L., Edmondson R., O'Connell R. L., Sjoquist K. M., Andrews J., Jyothirmayi R., Beale P., Bonaventura T., Goh J., Hall M., Clamp A., Green J., Lord R., Amant F., Alexander L., Carty K., Paul J., Scurry J., Millan D., Nottley S. & Friedlander M. (20190826). Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903. : Gynecologic oncology.
Chicago
Mileshkin Linda, Edmondson Richard, O'Connell Rachel L, Sjoquist Katrin M, Andrews John, Jyothirmayi Rema, Beale Philip, Bonaventura Tony, Goh Jeffrey, Hall Marcia, Clamp Andrew, Green John, Lord Rosemary, Amant Frédéric, Alexander Laura, Carty Karen, Paul James, Scurry James, Millan David, Nottley Steven and Friedlander Michael. 20190826. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903. : Gynecologic oncology.
Harvard
Mileshkin L., Edmondson R., O'Connell R. L., Sjoquist K. M., Andrews J., Jyothirmayi R., Beale P., Bonaventura T., Goh J., Hall M., Clamp A., Green J., Lord R., Amant F., Alexander L., Carty K., Paul J., Scurry J., Millan D., Nottley S. and Friedlander M. (20190826). Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903. : Gynecologic oncology.
MLA
Mileshkin Linda, Edmondson Richard, O'Connell Rachel L, Sjoquist Katrin M, Andrews John, Jyothirmayi Rema, Beale Philip, Bonaventura Tony, Goh Jeffrey, Hall Marcia, Clamp Andrew, Green John, Lord Rosemary, Amant Frédéric, Alexander Laura, Carty Karen, Paul James, Scurry James, Millan David, Nottley Steven and Friedlander Michael. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903. : Gynecologic oncology. 20190826.